Cytopenia clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients
open to eligible people ages 18 years and up
This observational, multi-center study aims to collect data in order to develop a novel, minimally invasive diagnostic tool for MDS based on peripheral blood profiling of circulating hematopoietic stem and progenitor cells (cHSPCs) using single-cell RNA sequencing and DNA sequencing.
at UCSD
Our lead scientists for Cytopenia research studies include Rafael Bejar.
Last updated: